Beta Bionics (BBNX) Change in Account Payables (2024 - 2026)

Beta Bionics has disclosed Change in Account Payables across 3 years of filings, most recently posting $2.9 million for Q2 2026.

• In Q2 2026, Change in Account Payables rose 403.87% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at $1.2 million (up 124.03% YoY), while the FY2025 annual figure was $2.1 million, up 38.48% from the prior year.
• Change in Account Payables came in at $2.9 million for Q2 2026 at Beta Bionics, up from -$3.3 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q2 2026 to a low of -$3.3 million in Q1 2026.
• Average Change in Account Payables over 3 years is $314200.0, with a median of $468500.0 recorded in 2024.
• Year-over-year, Change in Account Payables jumped 963.93% in 2025 and sank 3336.08% in 2026.
• Over 3 years, Change in Account Payables stood at -$61000.0 in 2024, then jumped by 963.93% to $527000.0 in 2025, then soared by 443.07% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $2.9 million in Q2 2026, -$3.3 million in Q1 2026, and $527000.0 in Q4 2025.